Immunomodulatory properties of the vaccine adjuvant alum.
about
NOD-Like Receptors in Infection, Immunity, and DiseasesInternational Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and diseaseRecent advances of vaccine adjuvants for infectious diseasesTailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.Salmonella Typhi Porins OmpC and OmpF Are Potent Adjuvants for T-Dependent and T-Independent Antigens.A New Adjuvant MTOM Mediates Mycobacterium tuberculosis Subunit Vaccine to Enhance Th1-Type T Cell Immune Responses and IL-2+ T Cells.Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in MiceThe Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice.Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants.Surfactin inducing mitochondria-dependent ROS to activate MAPKs, NF-κB and inflammasomes in macrophages for adjuvant activity.Particles from the Echinococcus granulosus laminated layer inhibit IL-4 and growth factor-driven Akt phosphorylation and proliferative responses in macrophages.Nanoparticle based-immunotherapy against allergy.Vaccine adjuvant uses of poly-IC and derivatives.Adjuvants in micro- to nanoscale: current state and future direction.Sterile inflammation induced by Carbopol elicits robust adaptive immune responses in the absence of pathogen-associated molecular patterns.Vaccine technologies: From whole organisms to rationally designed protein assemblies.Overview of Vaccine Adjuvants: Introduction, History, and Current Status.Strategies for designing synthetic immune agonists.Interactions Between Antigens and Nanoemulsion Adjuvants: Separation and Characterization Techniques.Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines.Germinal center enhancement by extended antigen availability.The effect of aqueous extract of Xinjiang Artemisia rupestris L. (an influenza virus vaccine adjuvant) on enhancing immune responses and reducing antigen dose required for immunity.Adjuvant formulations for virus-like particle (VLP) based vaccines.Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia.Porcine Dendritic Cells as an In Vitro Model to Assess the Immunological Behaviour of Streptococcus suis Subunit Vaccine Formulations and the Polarizing Effect of Adjuvants.A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infection.Evaluation of different chemical adjuvants on an avian influenza H6 DNA vaccine in chickens.Preclinical safety study of a recombinant Streptococcus pyogenes vaccine formulated with aluminum adjuvant.Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses.Secretory IgA as a vaccine carrier for delivery of HIV antigen to M cells.IL-33 released by alum is responsible for early cytokine production and has adjuvant properties.The Health Effects of Aluminum Exposure.Mechanistic insight into the impact of nanomaterials on asthma and allergic airway disease.Alum Activates the Bovine NLRP3 Inflammasome.Aluminum (Oxy)Hydroxide Nanosticks Synthesized in Bicontinuous Reverse Microemulsion Have Potent Vaccine Adjuvant Activity.Adaptive immune constraints on C. difficile vaccination.Modulation of Immune Responses by Particulate Materials.Ultrastructural Visualization of Vaccine Adjuvant Uptake In Vitro and In Vivo.
P2860
Q26775253-D70378B5-E01F-43AE-A1F5-1CE2778A3A56Q28081406-FF9D2B1E-5B29-4815-A2B7-C7ABBBB09884Q28083679-1C605954-4653-4DE3-80F8-DE9D54F5B02AQ30368736-67E0C15F-A3E6-4944-83BC-17A41D18F4B4Q30390832-94B29617-9A4C-4EFE-90FE-BB5C52A8E67DQ30400261-9C26A085-B52E-45CB-A968-B5574DEAA2D2Q33703027-2B014829-1D6A-4112-AD51-24B0CD429968Q34625185-8F5587AF-878E-4BF6-A7D9-7351AC8F8A01Q35940724-6F70889A-B996-43EC-919D-B3081F1C90C9Q35998757-EBE79023-8A93-4DC4-AC2B-1CF4F678303AQ36466129-8D32E6D3-BFB5-468A-8D1E-CC5D6FD2BD13Q37501222-2B73544D-0C9D-415F-BB16-50921597D758Q37501428-FD208F21-5595-4C6D-B600-C6BA35B87993Q38257645-DBEC6CC1-02D2-4F0B-A65E-13F6D398D9C2Q38259510-55C80667-FBA0-45D4-812A-DAC0C0B2F2D3Q38520210-C62BDE3A-1582-426F-B09D-7522BE47559CQ38783989-BC9079D8-4906-41E3-AF4E-7E71FC2DE5B8Q38806558-37499799-5C00-4F8D-A4EB-5843D77C8B29Q38813523-78D53CC6-98B1-407F-A14E-6AA877234C43Q38841677-B5726E88-EE7B-45BE-8218-3578060EE2CDQ39310294-ADA7D037-6A43-456A-BDC6-A2E848817A84Q39450802-8E4491C2-8BBA-4603-8C9A-7196F9FC321AQ39454581-F69FE8C5-DDA2-4A62-9BBF-3EDD7B3E5EEAQ40070284-46BBA1F5-D091-42E0-8F5F-284C44D7E098Q40093469-F3D77EB4-C54D-482A-BAD4-463DE6276FB8Q40267074-2D29DEE1-1042-4E9E-AB4F-BB6C04A21332Q40284594-17AD6F3B-B725-4E7B-95EC-186F0A6CCC98Q40298230-3B917169-1A1C-475D-B6A7-967894463709Q40499124-F6826950-5B38-4974-8321-21CE5C0D4DBDQ40653017-C0DEB6DA-9CBA-4C35-AB9C-3795AF754AB9Q40726914-9D736113-E086-4E5F-BF1F-844CB46681BAQ41654336-73C9C591-607A-4F6B-B159-5C74ABFA5111Q41842923-D66B73AF-A0FE-4FEB-9B17-9A192798D52AQ42653169-F297313A-F91C-4FBE-9FF9-FCD2443714CEQ45817911-62C89BF3-FBFE-4D89-AC63-08EA0D9DE861Q47149467-6F848304-0C28-4605-90D7-8BBE9A8BF1D5Q48265935-21A70D40-0BD8-43BF-966B-005667A144F6Q50130012-51023492-205C-4E78-B919-FBE5157C2B94Q51336724-3C9009FA-E503-4BB8-8DDA-0335B0BAABD0Q53402216-C95808F2-ACB6-4F2D-89D7-816263FF8915
P2860
Immunomodulatory properties of the vaccine adjuvant alum.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immunomodulatory properties of the vaccine adjuvant alum.
@en
type
label
Immunomodulatory properties of the vaccine adjuvant alum.
@en
prefLabel
Immunomodulatory properties of the vaccine adjuvant alum.
@en
P1476
Immunomodulatory properties of the vaccine adjuvant alum.
@en
P2093
Ewa Oleszycka
P356
10.1016/J.COI.2013.12.007
P577
2014-01-23T00:00:00Z